Published in Obesity and Diabetes Week, June 7th, 2010
"The primary outcome was change in glycated haemoglobin (HbA(1c)) from baseline to endpoint. Least squares mean (+/- se) changes in HbA(1c) were similar between groups, meeting non-inferiority (margin, 0.4%): -0.69 +/- 0.07% for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.